We are live on
!
Find out more
EMG
ETF Managers Group Portfolio holdings
AUM
$3.1B
Turnover
42.86%
1-Year Est. Return
17.12%
This Fund
S&P 500
This Quarter
Est. Return
+5.57%
1 Year Est. Return
-17.12%
3 Year Est. Return
+77.69%
5 Year Est. Return
+63.88%
10 Year Est. Return
–
AUM
$6.13B
AUM Growth
+$505M
(+9%)
Cap. Flow
+$205M
Cap. Flow
% of AUM
3.34%
Top 10 Holdings %
Top 10 Hldgs %
19.96%
Holding
831
New
162
Increased
239
Reduced
241
Closed
184
Avg Time Held
1.7
years
Top 10 Avg Time Held
0.4
years
Top 20 Avg Time Held
0.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VALT
ETFMG Sit Ultra Short ETF
VALT
|
+$79.6M |
| 2 |
Tilray
TLRY
|
+$56.8M |
| 3 |
Aurora Cannabis
ACB
|
+$54.4M |
| 4 |
Canopy Growth
CGC
|
+$51.6M |
| 5 |
KNBE
KnowBe4, Inc. Class A Common Stock
KNBE
|
+$51.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
+$187M |
| 2 |
APHA
Aphria Inc. Common Shares
APHA
|
+$182M |
| 3 |
Hecla Mining
HL
|
+$43.6M |
| 4 |
Mativ Holdings
MATV
|
+$21.5M |
| 5 |
BlackBerry
BB
|
+$21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 42.87% |
| 2 | Healthcare | 15.14% |
| 3 | Materials | 14.7% |
| 4 | Financials | 7.38% |
| 5 | Consumer Staples | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
626
Arbutus Biopharma
ABUS
$850M
| $90K | ﹤0.01% |
28,451
+2,442
| +9% | +$7.56K |
2020 Q2
4 quarters
|
|
627
DELISTED
HOOKIPA Pharma
HOOK
| $81K | ﹤0.01% |
879
-130
| -13% | -$17.3K |
2020 Q2
4 quarters
|
|
628
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
| $81K | ﹤0.01% |
504
-21
| -4% | -$3.57K |
2021 Q1
1 quarter
|
|
629
CorMedix
CRMD
$581M
| $80K | ﹤0.01% |
11,235
+1,392
| +14% | +$11.1K |
2020 Q2
4 quarters
|
|
630
Co-Diagnostics
CODX
$4.99M
| $75K | ﹤0.01% |
282
-7
| -2% | -$1.8K |
2020 Q2
4 quarters
|
|
631
Xunlei
XNET
$296M
| $74K | ﹤0.01% |
16,226
+572
| +4% | +$2.92K |
2020 Q3
3 quarters
|
|
632
Lunai Bioworks
LNAI
$3.74M
| $72K | ﹤0.01% |
176
-3
| -2% | -$978 |
2020 Q3
3 quarters
|
|
|
LHDX
633
DELISTED
Lucira Health, Inc. Common Stock
LHDX
| $67K | ﹤0.01% |
11,380
-15
| -0.1% | -$95 |
2021 Q1
1 quarter
|
|
634
Immunome
IMNM
$2.05B
| $61K | ﹤0.01% |
3,471
+221
| +7% | +$4.88K |
2021 Q1
1 quarter
|
|
|
PHAS
635
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
| $52K | ﹤0.01% |
14,179
+5,184
| +58% | +$17.3K |
2020 Q2
4 quarters
|
|
|
CFRX
636
DELISTED
ContraFect Corporation
CFRX
| $50K | ﹤0.01% |
145
+39
| +37% | +$12.8K |
2020 Q2
4 quarters
|
|
637
cbdMD
YCBD
$4.03M
| $48K | ﹤0.01% |
45
-50
| -53% | -$59.8K |
2020 Q4
2 quarters
|
|
638
Assembly Biosciences
ASMB
$419M
| $46K | ﹤0.01% |
987
+10
| +1% | +$495 |
2020 Q2
4 quarters
|
|
639
DELISTED
Enzo Biochem, Inc.
ENZ
| $44K | ﹤0.01% |
14,225
-446
| -3% | -$1.4K |
2020 Q2
4 quarters
|
|
640
Evaxion A/S
EVAX
$25.3M
| $43K | ﹤0.01% |
113
-5
| -4% | -$1.68K |
2021 Q1
1 quarter
|
|
|
IMV
641
DELISTED
IMV Inc. Common Shares
IMV
| $42K | ﹤0.01% |
1,979
-73
| -4% | -$1.86K |
2020 Q3
3 quarters
|
|
642
InflaRx
IFRX
$212M
| $38K | ﹤0.01% |
12,931
-395
| -3% | -$1.31K |
2021 Q1
1 quarter
|
|
643
DELISTED
Edgio, Inc. Common Stock
EGIO
| $38K | ﹤0.01% |
301
-22
| -7% | -$2.9K |
2020 Q2
4 quarters
|
|
|
ABTC
644
American Bitcoin Corp
ABTC
$593M
| – | – |
0
| – | – |
2021 Q2
0 quarters
|
|
645
Organon & Co
OGN
$3.61B
| $24K | ﹤0.01% |
+778
| New | +$25.6K |
2021 Q2
0 quarters
|
|
646
Marathon Digital Holdings
MARA
$3.22B
| $6K | ﹤0.01% |
176
-24,691
| -99% | -$783K |
2021 Q1
1 quarter
|
|
647
Automatic Data Processing
ADP
$113B
| – | – |
-2,356
| Closed | -$443K | – |
|
648
Aflac
AFL
$59.2B
| – | – |
-9,726
| Closed | -$504K | – |
|
649
Arthur J. Gallagher & Co
AJG
$64.1B
| – | – |
-3,954
| Closed | -$497K | – |
|
650
Albemarle
ALB
$11.6B
| – | – |
-5,707
| Closed | -$830K | – |
|
Similar funds
PFM
HT
JCG
QA
BFG
IMOV
ETF Managers Group's Q2 2021 Portfolio in Review
As of Q2 2021, ETF Managers Group held 831 positions worth $6.13B, up 9% from $5.63B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
ETF Managers Group deployed $205M of net new capital in Q2 2021, opening 162 new positions and adding to 239 existing holdings. Its largest new stake was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
By sector, the portfolio is most concentrated in Technology at 43% of assets, up from 42% a quarter earlier, followed by Healthcare and Materials.
On the sell side, the largest reduction was Hecla Mining, an estimated $43.6M trimmed.
- ETF Managers Group's largest Q2 2021 buy was KnowBe4, Inc. Class A Common Stock: 2,250,843 shares worth $74.9M.
- ETF Managers Group added most to ETFMG Sit Ultra Short ETF in Q2 2021, an estimated $79.6M increase.
- ETF Managers Group's biggest Q2 2021 reduction was Hecla Mining, cutting an estimated $43.6M.
- ETF Managers Group fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $187M.
- ETF Managers Group's ten largest holdings make up 20% of its $6.13B portfolio in Q2 2021.
- ETF Managers Group opened 162 new positions and closed 184 in Q2 2021.
- ETF Managers Group's portfolio value rose 9% quarter-over-quarter to $6.13B.
Based on ETF Managers Group's 13F filing for Q2 2021, filed 16 Aug 2021.